<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CEP</journal-id>
<journal-title-group>
<journal-title>Clinical and Experimental Pediatrics</journal-title><abbrev-journal-title>Clin Exp Pediatr</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2713-4148</issn>
<publisher>
<publisher-name>Korean Pediatric Society</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3345/cep.2019.01431</article-id>
<article-id pub-id-type="publisher-id">cep-2019-01431</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
<subj-group subj-group-type="heading">
<subject>Neonatology (Perinatology)</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Robati Anaraki</surname><given-names>Mahmoud</given-names></name>
<degrees>DDS</degrees>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="af1-cep-2019-01431"><sup>1</sup></xref>
<xref ref-type="aff" rid="af2-cep-2019-01431"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nouri-Vaskeh</surname><given-names>Masoud</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af3-cep-2019-01431"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5897-7883</contrib-id>
<name><surname>Abdoli Oskoei</surname><given-names>Shahram</given-names></name>
<degrees>MD</degrees>
<degrees>MSc</degrees>
<xref ref-type="corresp" rid="c1-cep-2019-01431"/>
<xref ref-type="aff" rid="af4-cep-2019-01431"><sup>4</sup></xref>
</contrib>
<aff id="af1-cep-2019-01431">
<label>1</label>Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz, <country>Iran</country></aff>
<aff id="af2-cep-2019-01431">
<label>2</label>Department of Prosthodontics, Dental School, Tabriz University of Medical Sciences, Tabriz, <country>Iran</country></aff>
<aff id="af3-cep-2019-01431">
<label>3</label>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, <country>Iran</country></aff>
<aff id="af4-cep-2019-01431">
<label>4</label>Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, <country>Iran</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-cep-2019-01431">Corresponding author: Shahram Abdoli Oskouie, MD, MSc. Pediatric Health Research Center, Tabriz Children Hospital, Sheshgelan St., Tabriz 5136735886, Iran E-mail: <email>shahram.oskouei@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>4</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>5</month>
<year>2020</year></pub-date>
<volume>64</volume>
<issue>4</issue>
<fpage>172</fpage>
<lpage>179</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2019</year></date>
<date date-type="rev-recd">
<day>14</day>
<month>4</month>
<year>2020</year></date>
<date date-type="accepted">
<day>29</day>
<month>4</month>
<year>2020</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000a9; 2021 by The Korean Pediatric Society</copyright-statement>
<copyright-year>2021</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract>
<sec><title>Background</title>
<p>Evidence shows that fluconazole prophylaxis is an effective treatment against invasive fungal infections in preterm neonates, however, the most efficient schedule of fluconazole prophylaxis for the colonization and mortality of invasive candidiasis (IC) is unknown.</p></sec>
<sec><title>Purpose</title>
<p>This systematic review and meta-analysis aimed to assess the efficiency of different prophylactic fluconazole schedules in controlling IC colonization, infection, and mortality in very low birth weight (VLBW) and extremely low birth weight (ELBW) infants in neonatal intensive care units.</p></sec>
<sec><title>Methods</title>
<p>We searched the PubMed, Scopus, Embase, and Cochrane databases using the keywords &#x0201c;candida,&#x0201d; &#x0201c;invasive candidiasis,&#x0201d; &#x0201c;IC,&#x0201d; &#x0201c;fluconazole prophylaxis,&#x0201d; &#x0201c;preterm infants,&#x0201d; &#x0201c;very low birth weight infants,&#x0201d; &#x0201c;VLBW,&#x0201d; &#x0201c;extremely low birth weight,&#x0201d; and &#x0201c;ELBW.&#x0201d;</p></sec>
<sec><title>Results</title>
<p>Mortality was significantly decreased in a meta-analysis of studies using different fluconazole prophylaxis regimens. The meta-analysis also indicated a significant decrease in the incidence of IC-associated mortality in ELBW infants using the same fluconazole prophylaxis schedules.</p></sec>
<sec><title>Conclusion</title>
<p>Future studies should explore the effectiveness of other different fluconazole prophylaxis schedules on IC colonization, infection, and mortality.</p></sec></abstract>
<kwd-group>
<kwd>Preterm infants</kwd>
<kwd>Very low birth weight</kwd>
<kwd>Extremely low birth weight</kwd>
<kwd>Fluconazole</kwd>
<kwd>Invasive candidiasis</kwd>
</kwd-group>
</article-meta>
<notes>
<title>Key message</title>
<boxed-text>
<p>&#x000b7; Mortality is decreased significantly in meta-analysis of studies in different regimen of fluconazole prophylaxis.</p>
<p>&#x000b7; Significant decrease was seen in incidence of invasive candidiasis-associated mortality in extremely low birth weight infants in same schedules of prophylaxis.</p>
<p>&#x000b7; More studies required to relief the concerns.</p>
</boxed-text>
</notes>
</front>
<body>
<p><xref rid="f7-cep-2019-01431" ref-type="fig"/></p>
<p><bold>Graphical abstract.</bold> In a systematic review and meta-analysis, the efficiency of different prophylactic fluconazole schedules in controlling invasive candidiasis (IC) colonization, infection, and mortality were assessed in very low birth weight (VLBW) and extremely low birth weight (ELBW) infants in neonatal intensive care units. There was a significant decrease in the incidence of IC-associated mortality in ELBW infants using the same fluconazole prophylaxis schedules. RR, risk ratio.</p>
<sec sec-type="intro">
<title>Introduction</title>
<p>Invasive candidiasis (IC) in very low birth weight (VLBW) infants can be fatal and often results in neurodevelopment impairment. IC as a fungal infection in the blood and other sterile body liquids is a frequent cause of mortality in VLBW infants. Despite antifungal treatment, patients with IC have a mortality rate of 20%&#x02013;60%, while surviving babies may develop neurodevelopmental impairments &#x0005b;<xref ref-type="bibr" rid="b1-cep-2019-01431">1</xref>,<xref ref-type="bibr" rid="b2-cep-2019-01431">2</xref>&#x0005d;.</p>
<p>The extensive involvement of IC in the neonatal intensive care unit (NICU) is related to immaturity of the immune system and other risk factors including prematurity, intratracheal intubation or catheterization, surgery, prevention of infection, and the administration of antibiotics and corticosteroids. Fungal infection in neonates often originates from <italic>Candida albicans</italic> and on recently <italic>Candida parapsilosis</italic> &#x0005b;<xref ref-type="bibr" rid="b3-cep-2019-01431">3</xref>-<xref ref-type="bibr" rid="b7-cep-2019-01431">7</xref>&#x0005d;. Successive control of candidiasis in infants requires proper and effective antifungal and supportive treatments to prevent IC &#x0005b;<xref ref-type="bibr" rid="b3-cep-2019-01431">3</xref>,<xref ref-type="bibr" rid="b4-cep-2019-01431">4</xref>&#x0005d;. A progressive fluconazole prophylaxis showed efficiency, immunity, and prolonged positive neurodevelopmental results in NICU infants in an evaluation at 2 years of age, with more than 15% of the risk consisting of problems such as profound bilateral hearing loss, severe cognitive delay, and severe cerebral palsy &#x0005b;<xref ref-type="bibr" rid="b8-cep-2019-01431">8</xref>-<xref ref-type="bibr" rid="b14-cep-2019-01431">14</xref>&#x0005d;. In addition, antifungal prophylaxis reduces the incidence of mortality due to invasive fungal infection in VLBW infants &#x0005b;<xref ref-type="bibr" rid="b15-cep-2019-01431">15</xref>&#x0005d;.</p>
<p>A meta-analysis of 5 randomized clinical trials (RCTs) demonstrated that prophylaxis consisting of different 42-day fluconazole treatment schedules effectively controlled mortality compared to 28-day treatment &#x0005b;<xref ref-type="bibr" rid="b16-cep-2019-01431">16</xref>&#x0005d;. Several studies compared different fluconazole doses and administration schedules to identify the best treatment option &#x0005b;<xref ref-type="bibr" rid="b10-cep-2019-01431">10</xref>,<xref ref-type="bibr" rid="b17-cep-2019-01431">17</xref>,<xref ref-type="bibr" rid="b18-cep-2019-01431">18</xref>&#x0005d;; although it remains unknown which schedule and treatment dose is most efficient for controlling colonization (implantation and growth of a microorganism on a host), mortality (as the quality being subject to death), and IC in VLBW infants &#x0005b;<xref ref-type="bibr" rid="b19-cep-2019-01431">19</xref>&#x0005d;.</p>
<p>The current systematic review and meta-analysis aimed to evaluate the different regimens to identify the most efficient fluconazole prophylaxis schedule against IC in VLBW infants.</p>
</sec>
<sec sec-type="methods">
<title>Methods</title>
<sec>
<title>1. Search strategy</title>
<p>This systematic review and meta-analysis was conducted according to the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines &#x0005b;<xref ref-type="bibr" rid="b20-cep-2019-01431">20</xref>&#x0005d;. Two investigators independently searched the PubMed, Scopus, Embase, and Cochrane databases for all eligible studies. Forward citation tracking was also performed to identify additional relevant studies. The keywords used in the search were &#x0201c;invasive candidiasis,&#x0201d; &#x0201c;candida,&#x0201d; &#x0201c;fluconazole prophylaxis,&#x0201d; &#x0201c;preterm infants,&#x0201d; &#x0201c;very low birth weight infants,&#x0201d; &#x0201c;VLBW,&#x0201d; &#x0201c;extremely low birth weight,&#x0201d; and &#x0201c;ELBW.&#x0201d; Two researchers independently searched for all relevant English articles published between 2001 and January 2018 and then performed forward citation tracking. The selected studies were RCTs and cohort studies with historical controls that explored the effect of prophylaxis with fluconazole in first 24 hours of life in VLBW infants on the incidence of IC colonization and mortality rates versus placebo or without fluconazole prophylaxis. Methodological quality was assessed using standardized methods, for instance, the Newcastle-Ottawa Scale was used to assess cohort studies &#x0005b;<xref ref-type="bibr" rid="b21-cep-2019-01431">21</xref>&#x0005d;. The results were compared, and any questions or discrepancies were resolved through iteration and consensus.</p>
</sec>
<sec>
<title>2. Data extraction</title>
<p>The following data were extracted from the retrieved studies: baseline characteristics (authors, year of publication, number of patients, birth weight, and antifungal therapy characteristics) and outcomes of interest (incidence of proven IC, colonization, overall mortality, and IC-related mortality). A total of 174 articles were selected: 43 from PubMed, 32 from Scopus, 15 from Embase, 21 from Cochrane, and 63 from the manual search. Among the 174 articles, 84 were duplicated and 90 remained. Of them, 74 were excluded, including 29 reviews and expert commentary, 9 epidemiology of IC articles, 7 case reports, 5 case-control articles, 3 drug schedules and hygiene in NICU, 9 studies of pharmacokinetics of antifungal drugs, and 12 with unrelated titles from original articles describing antifungal prophylaxis use in VLBW infants. Sixteen studies were eligible for comparative evaluation (<xref rid="f1-cep-2019-01431" ref-type="fig">Fig. 1</xref>). As mentioned in <xref rid="f1-cep-2019-01431" ref-type="fig">Fig. 1</xref>, <xref rid="f3-cep-2019-01431" ref-type="fig">3</xref> studies that postponed starting prophylaxis more than 24 hours after birth were excluded. The primary outcome of this meta-analysis was mortality, while the secondary outcomes were colonization and IC.</p>
</sec>
<sec>
<title>3. Included studies</title>
<p>For assessing the incidence of IC and mortality in VLBW and extremely low birth weight (ELBW) infants, fluconazole prophylaxis regimens used in 16 studies were reviewed &#x0005b;<xref ref-type="bibr" rid="b8-cep-2019-01431">8</xref>-<xref ref-type="bibr" rid="b12-cep-2019-01431">12</xref>,<xref ref-type="bibr" rid="b15-cep-2019-01431">15</xref>, <xref ref-type="bibr" rid="b22-cep-2019-01431">22</xref>-<xref ref-type="bibr" rid="b31-cep-2019-01431">31</xref>&#x0005d;. The study characteristics are mentioned in <xref rid="t1-cep-2019-01431" ref-type="table">Table 1</xref>. All schedules consisted of 3- or 6-mg/kg fluconazole mostly for 4&#x02013;6 weeks in 7 schedules for infants with a birth weight less than 1,500 g.</p>
<p>IC and/or mortality with or without colonization and IC-associated mortality were evaluated in 4,486 subjects in 9 RCTs and 8 cohort studies with 1,358 and 3,128 subjects, respectively, to compare the effect of prophylaxis with fluconazole and treatment with placebo or no prophylaxis in ELBW and VLBW infants. <xref rid="t2-cep-2019-01431" ref-type="table">Table 2</xref> shows the outcomes in addition the author&#x02019;s name and year of the publication of every study. The meta-analysis included 4 groups of 2 or 3 studies each that had same study protocol, dose, frequency, and duration.</p>
</sec>
<sec>
<title>4. Statistical analyses</title>
<p>In every study, the risk ratios (RRs) for colonization, IC, IC-associated mortality, and mortality were determined by meta-analysis and the pooled RR was calculated to assess outcomes. The <italic>I</italic><sup>2</sup> statistics and Cochrane Q were derived to estimate the fraction of variability between study RRs due to heterogeneity rather than chance. <italic>I</italic><sup>2</sup> values of 25&#x02013;75 and <italic>I</italic><sup>2</sup> &gt;75 were considered middle and high heterogeneity, respectively. In cases of heterogeneity, the random-effects model was used to determine the overall effect size &#x0005b;<xref ref-type="bibr" rid="b32-cep-2019-01431">32</xref>&#x0005d;. Egger regression test and a funnel plot were used to assess publication bias. Statistical analyses were performed using comprehensive meta-analysis ver. 2.0 software (Biostat Inc., Englewood, CO, USA), and <italic>P</italic> values &lt;0.05 were considered significant.</p>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>1. IC-associated mortality</title>
<p>Mortality with or without IC was surveyed of the 7 RCTs and 9 cohort studies. Six studies showed significantly decreased mortality and/or IC-associated mortality in the prophylaxis groups. Rueda et al. &#x0005b;<xref ref-type="bibr" rid="b26-cep-2019-01431">26</xref>&#x0005d; showed less IC-associated mortality in relation to all-cause death by prophylaxis year (<italic>P</italic>&lt;0.05), while most deaths occurred in infants less than 1,000 g and neonates born at less than 31-week gestation. Kirpal et al. &#x0005b;<xref ref-type="bibr" rid="b31-cep-2019-01431">31</xref>&#x0005d; reported that IC-associated mortality was significantly decreased with prophylaxis use in infants (<xref rid="t2-cep-2019-01431" ref-type="table">Table 2</xref>). Regardless of schedule, the current meta-analysis showed that prophylaxis with fluconazole can significantly decrease the IC-associated mortality of VLBW infants weighing &#x02264;1,000 g (<italic>P</italic>&#x0003d;0.011) (RR, 0.068; 95% confidence interval &#x0005b;CI&#x0005d;, 0.009&#x02013;0.543) (<xref rid="f2-cep-2019-01431" ref-type="fig">Figs. 2</xref>, <xref rid="f3-cep-2019-01431" ref-type="fig">3</xref>) with different regimens and the administration of 3-mg fluconazole every 3 days in weeks 1 and 2, then every 2 days in weeks 3 and 4, and every day in weeks 5 and 6 decreased mortality rates significantly (<italic>P</italic>&#x0003d;0.023) (RR, 0.780; 95% CI, 0.629&#x02013;0.966). The heterogeneity was not significant in these 2 outcomes as shown in <xref rid="t3-cep-2019-01431" ref-type="table">Table 3</xref> (group 2 for mortality: <italic>Q</italic>&#x0003d;3.20, degrees of freedom &#x0005b;<italic>df</italic>&#x0005d;&#x0003d;2, <italic>P</italic>&#x0003d;0.202, <italic>I</italic><sup>2</sup>&#x0003d;37.486; group 2 for IC-associated mortality: <italic>Q</italic>&#x0003d;0.09, <italic>df</italic>&#x0003d;1, <italic>P</italic>&#x0003d;0.768, <italic>I</italic><sup>2</sup>&lt;0.001).</p>
</sec>
<sec>
<title>2. Colonization and IC</title>
<p>The colonization of <italic>Candida</italic> spp. in different locations (endotracheal secretion, nasopharynx, periumbilical region, perineum, gastric aspirate, skin) was evaluated in 7 studies (<xref rid="t2-cep-2019-01431" ref-type="table">Table 2</xref>). All showed significantly decreased colonization, and the meta-analysis showed that 6 mg fluconazole administered every 3 days in week 1 and every day in the following 3 weeks can prevent colonization in VLBW infants (<xref rid="f4-cep-2019-01431" ref-type="fig">Fig. 4</xref>) (<italic>P</italic>&lt;001; RR, 0.350; 95% CI, 0.223&#x02013;0.551). Additionally, IC was decreased significantly on day 10, but 3 studies in the prophylaxis group versus placebo or the no prophylaxis group reported data in different groups, most of which were not suitable for analysis or the assessed schedules ineffectively prevented IC in the meta-analysis (<xref rid="f5-cep-2019-01431" ref-type="fig">Fig. 5</xref>). The heterogeneity was not significant in these outcomes as depicted in <xref rid="t3-cep-2019-01431" ref-type="table">Table 3</xref> (group 4 for colonization: <italic>Q</italic>&#x0003d;0.06, <italic>df</italic>&#x0003d;1, <italic>P</italic>&#x0003d;0.813, <italic>I</italic><sup>2</sup>&lt;0.001; group 4 for IC: <italic>Q</italic>&#x0003d;0.01, <italic>df</italic>&#x0003d;1, <italic>P</italic>&#x0003d;0.813, <italic>I</italic><sup>2</sup>&lt;0.001). The funnel plot of standard error by log RR is shown in <xref rid="f6-cep-2019-01431" ref-type="fig">Fig. 6</xref>. The results of Egger regression test were <italic>t</italic>&#x0003d;0.38, <italic>df</italic>&#x0003d;7.0, and <italic>P</italic>&#x0003d;0.71.</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Fungal invasion is a severe infection in VLBW infants that can result in mortality or otherwise affect quality of life. Prophylaxis with fluconazole both decreases mortality and decreases the incidence of neurodevelopmental impairments. Fluconazole prophylaxis is currently recommended for NICUadmitted infants with a &#x02265;5% risk of an incidence of IC by many continental neonatology associations &#x0005b;<xref ref-type="bibr" rid="b33-cep-2019-01431">33</xref>-<xref ref-type="bibr" rid="b37-cep-2019-01431">37</xref>&#x0005d;.</p>
<p>The current meta-analysis showed that prophylaxis with fluconazole administered according to 1 of 7 surveyed schedules compared with no prophylaxis or placebo can significantly decrease the overall mortality rates of ELBW infants less than 1,000 g (RR, 0.780; 95% CI, 0.629&#x02013;0.966). This effect was driven by the studies that used a dose of 3-mg/kg fluconazole every 3 days in weeks 1 and 2, every 2 days in weeks 3 and 4, and every day in weeks 5 and 6. IC-associated mortality also decreased significantly with fluconazole prophylaxis whenever colonization prevented with a dose of 6-mg/kg fluconazole every 3 days in week 1 and every day in the following 3 weeks in 2 RCTs of VLBW infants weighing &lt;1,500 g.</p>
<p>Some studies reported that prophylaxis with fluconazole can decrease IC and/or colonization without significantly affecting mortality &#x0005b;<xref ref-type="bibr" rid="b38-cep-2019-01431">38</xref>-<xref ref-type="bibr" rid="b40-cep-2019-01431">40</xref>&#x0005d;.</p>
<p>A candidiasis management guideline recommended intravenous or oral fluconazole prophylaxis in nurseries with high rates (&gt;10%) of IC using 3&#x02013;6 mg/kg twice weekly for 6 weeks in neonates with birth weights &lt;1,000 g. Whenever this schedule with 3-mg/kg fluconazole assessed for preventing IC-associated mortality in current study had no significant effect (<italic>P</italic>&#x0003d;0.06) &#x0005b;<xref ref-type="bibr" rid="b36-cep-2019-01431">36</xref>&#x0005d;, 3-mg/kg fluconazole every 3 days in weeks 1 and 2, every 2 days in weeks 3 and 4, and every day in weeks 5 and 6 prevented IC-associated mortality (<italic>P</italic>&#x0003d;0.011). The differences in results between these studies and the current study can be attributed to differences in the studies assessed, the proposed endpoints, and the populations under study.</p>
<p>There were some limitations to the current study. First, the differences in study duration and medication administration might have created heterogeneity in the outcomes. Second, the endpoints differed between the current study and surveyed studies. Third, no antifungals other than fluconazole were investigated. Fourth, the subjects&#x02019; gestational ages and birth weights were not evaluated in this study. And finally, the following potential issues with the introduction of fluconazole prophylaxis to NICU patients should be considered: drug side effects, changes in susceptibility of antifungal agents, changes in pathogenic strains, and emergence of resistant strains. Despite more limitations in similar studies that should be considered when evaluating and generalizing their results, the high incidence of IC-associated mortality and complications in premature infants even after treatment resulted in the recommendation of preventive measures, including the use of prophylactic fluconazole &#x0005b;<xref ref-type="bibr" rid="b16-cep-2019-01431">16</xref>&#x0005d;.</p>
<p>In conclusion, the study showed the effectiveness of 2 schedules of fluconazole prophylaxis with a significant reduction in the incidence of colonization by <italic>Candida</italic> spp., IC-associated mortality, and total mortality. This effect was further driven by studies that used 3-mg/kg fluconazole every 3 days in weeks 1 and 2, every 2 days in weeks 3 and 4, and every day in weeks 5 and 6. Concerns about the use of fluconazole prophylaxis included side effects, induction of resistance, and effect on mortality and IC.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>No potential conflict of interest relevant to this article was reported.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-cep-2019-01431">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Benjamin</surname><given-names>DK</given-names><suffix>Jr</suffix></name>
<name><surname>Stoll</surname><given-names>BJ</given-names></name>
<name><surname>Fanaroff</surname><given-names>AA</given-names></name>
<name><surname>McDonald</surname><given-names>SA</given-names></name>
<name><surname>Oh</surname><given-names>W</given-names></name>
<name><surname>Higgins</surname><given-names>RD</given-names></name>
<etal/>
</person-group>
<article-title>Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months</article-title>
<source>Pediatrics</source>
<year>2006</year>
<volume>117</volume>
<fpage>84</fpage>
<lpage>92</lpage>
</element-citation></ref>
<ref id="b2-cep-2019-01431">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>IPDTOC Working Group</collab>
</person-group>
<article-title>Prevalence at birth of cleft lip with or without cleft palate: data from the International Perinatal Database of Typical Oral Clefts (IPDTOC)</article-title>
<source>Cleft Palate Craniofac J</source>
<year>2011</year>
<volume>48</volume>
<fpage>66</fpage>
<lpage>81</lpage>
</element-citation></ref>
<ref id="b3-cep-2019-01431">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rao</surname><given-names>S</given-names></name>
<name><surname>Ali</surname><given-names>U</given-names></name>
</person-group>
<article-title>Systemic fungal infections in neonates</article-title>
<source>J Postgrad Med</source>
<year>2005</year>
<volume>51 Suppl 1</volume>
<fpage>S27</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b4-cep-2019-01431">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Steinbach</surname><given-names>WJ</given-names></name>
</person-group>
<article-title>Epidemiology of invasive fungal infections in neonates and children</article-title>
<source>Clin Microbiol Infect</source>
<year>2010</year>
<volume>16</volume>
<fpage>1321</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b5-cep-2019-01431">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pammi</surname><given-names>M</given-names></name>
<name><surname>Holland</surname><given-names>L</given-names></name>
<name><surname>Butler</surname><given-names>G</given-names></name>
<name><surname>Gacser</surname><given-names>A</given-names></name>
<name><surname>Bliss</surname><given-names>JM</given-names></name>
</person-group>
<article-title><italic>Candida parapsilosis</italic> is a significant neonatal pathogen: a systematic review and meta-analysis</article-title>
<source>Pediatr Infect Dis J</source>
<year>2013</year>
<volume>32</volume>
<fpage>e206</fpage>
<lpage>16</lpage>
</element-citation></ref>
<ref id="b6-cep-2019-01431">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chow</surname><given-names>BD</given-names></name>
<name><surname>Linden</surname><given-names>JR</given-names></name>
<name><surname>Bliss</surname><given-names>JM</given-names></name>
</person-group>
<article-title><italic>Candida parapsilosis</italic> and the neonate: epidemiology, virulence and host defense in a unique patient setting</article-title>
<source>Expert Rev Anti Infect Ther</source>
<year>2012</year>
<volume>10</volume>
<fpage>935</fpage>
<lpage>46</lpage>
</element-citation></ref>
<ref id="b7-cep-2019-01431">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arsenault</surname><given-names>AB</given-names></name>
<name><surname>Bliss</surname><given-names>JM</given-names></name>
</person-group>
<article-title>Neonatal candidiasis: new insights into an old problem at a unique host-pathogen interface</article-title>
<source>Curr Fungal Infect Rep</source>
<year>2015</year>
<volume>9</volume>
<fpage>246</fpage>
<lpage>52</lpage>
</element-citation></ref>
<ref id="b8-cep-2019-01431">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufman</surname><given-names>D</given-names></name>
<name><surname>Boyle</surname><given-names>R</given-names></name>
<name><surname>Hazen</surname><given-names>KC</given-names></name>
<name><surname>Patrie</surname><given-names>JT</given-names></name>
<name><surname>Robinson</surname><given-names>M</given-names></name>
<name><surname>Donowitz</surname><given-names>LG</given-names></name>
</person-group>
<article-title>Fluconazole prophylaxis against fungal colonization and infection in preterm infants</article-title>
<source>N Engl J Med</source>
<year>2001</year>
<volume>345</volume>
<fpage>1660</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b9-cep-2019-01431">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kicklighter</surname><given-names>SD</given-names></name>
<name><surname>Springer</surname><given-names>SC</given-names></name>
<name><surname>Cox</surname><given-names>T</given-names></name>
<name><surname>Hulsey</surname><given-names>TC</given-names></name>
<name><surname>Turner</surname><given-names>RB</given-names></name>
</person-group>
<article-title>Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant</article-title>
<source>Pediatrics</source>
<year>2001</year>
<volume>107</volume>
<fpage>293</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b10-cep-2019-01431">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Manzoni</surname><given-names>P</given-names></name>
<name><surname>Stolfi</surname><given-names>I</given-names></name>
<name><surname>Pugni</surname><given-names>L</given-names></name>
<name><surname>Decembrino</surname><given-names>L</given-names></name>
<name><surname>Magnani</surname><given-names>C</given-names></name>
<name><surname>Vetrano</surname><given-names>G</given-names></name>
<etal/>
</person-group>
<article-title>A multicenter, randomized trial of prophylactic fluconazole in preterm neonates</article-title>
<source>N Engl J Med</source>
<year>2007</year>
<volume>356</volume>
<fpage>2483</fpage>
<lpage>95</lpage>
</element-citation></ref>
<ref id="b11-cep-2019-01431">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Parikh</surname><given-names>TB</given-names></name>
<name><surname>Nanavati</surname><given-names>RN</given-names></name>
<name><surname>Patankar</surname><given-names>CV</given-names></name>
<name><surname>Rao</surname><given-names>S</given-names></name>
<name><surname>Bisure</surname><given-names>K</given-names></name>
<name><surname>Udani</surname><given-names>RH</given-names></name>
<etal/>
</person-group>
<article-title>Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants</article-title>
<source>Indian Pediatr</source>
<year>2007</year>
<volume>44</volume>
<fpage>830</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b12-cep-2019-01431">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Healy</surname><given-names>CM</given-names></name>
<name><surname>Campbell</surname><given-names>JR</given-names></name>
<name><surname>Zaccaria</surname><given-names>E</given-names></name>
<name><surname>Baker</surname><given-names>CJ</given-names></name>
</person-group>
<article-title>Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species</article-title>
<source>Pediatrics</source>
<year>2008</year>
<volume>121</volume>
<fpage>703</fpage>
<lpage>10</lpage>
</element-citation></ref>
<ref id="b13-cep-2019-01431">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufman</surname><given-names>DA</given-names></name>
<name><surname>Cuff</surname><given-names>AL</given-names></name>
<name><surname>Wamstad</surname><given-names>JB</given-names></name>
<name><surname>Boyle</surname><given-names>R</given-names></name>
<name><surname>Gurka</surname><given-names>MJ</given-names></name>
<name><surname>Grossman</surname><given-names>LB</given-names></name>
<etal/>
</person-group>
<article-title>Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age</article-title>
<source>J Pediatr</source>
<year>2011</year>
<volume>158</volume>
<fpage>759</fpage>
<lpage>65</lpage>
<comment>e1</comment>
</element-citation></ref>
<ref id="b14-cep-2019-01431">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Friedman</surname><given-names>S</given-names></name>
<name><surname>Richardson</surname><given-names>SE</given-names></name>
<name><surname>Jacobs</surname><given-names>SE</given-names></name>
<name><surname>O&#x00027;Brien</surname><given-names>K</given-names></name>
</person-group>
<article-title>Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome</article-title>
<source>Pediatr Infect Dis J</source>
<year>2000</year>
<volume>19</volume>
<fpage>499</fpage>
<lpage>504</lpage>
</element-citation></ref>
<ref id="b15-cep-2019-01431">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>HS</given-names></name>
<name><surname>Shin</surname><given-names>SH</given-names></name>
<name><surname>Choi</surname><given-names>CW</given-names></name>
<name><surname>Kim</surname><given-names>EK</given-names></name>
<name><surname>Choi</surname><given-names>EH</given-names></name>
<etal/>
</person-group>
<article-title>Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study</article-title>
<source>BMC Pediatr</source>
<year>2016</year>
<volume>16</volume>
<fpage>67</fpage>
</element-citation></ref>
<ref id="b16-cep-2019-01431">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Che</surname><given-names>D</given-names></name>
<name><surname>Zhou</surname><given-names>H</given-names></name>
<name><surname>Li</surname><given-names>T</given-names></name>
<name><surname>Wu</surname><given-names>B</given-names></name>
</person-group>
<article-title>Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled trials</article-title>
<source>BMC Infect Dis</source>
<year>2016</year>
<volume>16</volume>
<fpage>312</fpage>
</element-citation></ref>
<ref id="b17-cep-2019-01431">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufman</surname><given-names>D</given-names></name>
<name><surname>Boyle</surname><given-names>R</given-names></name>
<name><surname>Hazen</surname><given-names>KC</given-names></name>
<name><surname>Patrie</surname><given-names>JT</given-names></name>
<name><surname>Robinson</surname><given-names>M</given-names></name>
<name><surname>Grossman</surname><given-names>LB</given-names></name>
</person-group>
<article-title>Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of &lt;1000 grams birth weight</article-title>
<source>J Pediatr</source>
<year>2005</year>
<volume>147</volume>
<fpage>172</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b18-cep-2019-01431">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Leonart</surname><given-names>LP</given-names></name>
<name><surname>Tonin</surname><given-names>FS</given-names></name>
<name><surname>Ferreira</surname><given-names>VL</given-names></name>
<name><surname>Tavares da Silva Penteado</surname><given-names>S</given-names></name>
<name><surname>de Ara&#x000fa;jo Motta</surname><given-names>F</given-names></name>
<name><surname>Pontarolo</surname><given-names>R</given-names></name>
</person-group>
<article-title>Fluconazole doses used for prophylaxis of invasive fungal infection in neonatal intensive care units: a network meta-analysis</article-title>
<source>J Pediatr</source>
<year>2017</year>
<volume>185</volume>
<fpage>129</fpage>
<lpage>35</lpage>
<comment>e6</comment>
</element-citation></ref>
<ref id="b19-cep-2019-01431">
<label>19</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Dorland</surname><given-names>WAM</given-names></name>
</person-group>
<source>Dorland&#x00027;s illustrated medical dictionary</source>
<edition>32nd ed</edition>
<publisher-loc>Philadelphia (PA)</publisher-loc>
<publisher-name>Elsevier Health Sciences</publisher-name>
<year>2011</year>
</element-citation></ref>
<ref id="b20-cep-2019-01431">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Moher</surname><given-names>D</given-names></name>
<name><surname>Liberati</surname><given-names>A</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
<collab>PRISMA Group</collab>
</person-group>
<article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>
<source>PLoS Med</source>
<year>2009</year>
<volume>6</volume>
<elocation-id>e1000097</elocation-id>
</element-citation></ref>
<ref id="b21-cep-2019-01431">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lo</surname><given-names>CK</given-names></name>
<name><surname>Mertz</surname><given-names>D</given-names></name>
<name><surname>Loeb</surname><given-names>M</given-names></name>
</person-group>
<article-title>Newcastle-Ottawa Scale: comparing reviewers&#x00027; to authors&#x00027; assessments</article-title>
<source>BMC Med Res Methodol</source>
<year>2014</year>
<volume>14</volume>
<fpage>45</fpage>
</element-citation></ref>
<ref id="b22-cep-2019-01431">
<label>22</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name><surname>Jannatdoust</surname><given-names>A</given-names></name>
<name><surname>Imani</surname><given-names>V</given-names></name>
</person-group>
<article-title>The effect of prophylactic intravenous fluconazole on the clinical outcome of preterm infants during hospitalization</article-title>
<year>2015</year>
</element-citation></ref>
<ref id="b23-cep-2019-01431">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aghai</surname><given-names>ZH</given-names></name>
<name><surname>Mudduluru</surname><given-names>M</given-names></name>
<name><surname>Nakhla</surname><given-names>TA</given-names></name>
<name><surname>Amendolia</surname><given-names>B</given-names></name>
<name><surname>Longo</surname><given-names>D</given-names></name>
<name><surname>Kemble</surname><given-names>N</given-names></name>
<etal/>
</person-group>
<article-title>Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis</article-title>
<source>J Perinatol</source>
<year>2006</year>
<volume>26</volume>
<fpage>550</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b24-cep-2019-01431">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Healy</surname><given-names>CM</given-names></name>
<name><surname>Baker</surname><given-names>CJ</given-names></name>
<name><surname>Zaccaria</surname><given-names>E</given-names></name>
<name><surname>Campbell</surname><given-names>JR</given-names></name>
</person-group>
<article-title>Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit</article-title>
<source>J Pediatr</source>
<year>2005</year>
<volume>147</volume>
<fpage>166</fpage>
<lpage>71</lpage>
</element-citation></ref>
<ref id="b25-cep-2019-01431">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weitkamp</surname><given-names>JH</given-names></name>
<name><surname>Ozdas</surname><given-names>A</given-names></name>
<name><surname>LaFleur</surname><given-names>B</given-names></name>
<name><surname>Potts</surname><given-names>AL</given-names></name>
</person-group>
<article-title>Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure</article-title>
<source>J Perinatol</source>
<year>2008</year>
<volume>28</volume>
<fpage>405</fpage>
<lpage>11</lpage>
</element-citation></ref>
<ref id="b26-cep-2019-01431">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rueda</surname><given-names>K</given-names></name>
<name><surname>Moreno</surname><given-names>MT</given-names></name>
<name><surname>Espinosa</surname><given-names>M</given-names></name>
<name><surname>S&#x000e1;ez-Llorens</surname><given-names>X</given-names></name>
</person-group>
<article-title>Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country</article-title>
<source>Pediatr Infect Dis J</source>
<year>2010</year>
<volume>29</volume>
<fpage>1050</fpage>
<lpage>2</lpage>
</element-citation></ref>
<ref id="b27-cep-2019-01431">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aydemir</surname><given-names>C</given-names></name>
<name><surname>Oguz</surname><given-names>SS</given-names></name>
<name><surname>Dizdar</surname><given-names>EA</given-names></name>
<name><surname>Akar</surname><given-names>M</given-names></name>
<name><surname>Sarikabadayi</surname><given-names>YU</given-names></name>
<name><surname>Saygan</surname><given-names>S</given-names></name>
<etal/>
</person-group>
<article-title>Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants</article-title>
<source>Arch Dis Child Fetal Neonatal Ed</source>
<year>2011</year>
<volume>96</volume>
<fpage>F164</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b28-cep-2019-01431">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bertini</surname><given-names>G</given-names></name>
<name><surname>Perugi</surname><given-names>S</given-names></name>
<name><surname>Dani</surname><given-names>C</given-names></name>
<name><surname>Filippi</surname><given-names>L</given-names></name>
<name><surname>Pratesi</surname><given-names>S</given-names></name>
<name><surname>Rubaltelli</surname><given-names>FF</given-names></name>
</person-group>
<article-title>Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants</article-title>
<source>J Pediatr</source>
<year>2005</year>
<volume>147</volume>
<fpage>162</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b29-cep-2019-01431">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Manzoni</surname><given-names>P</given-names></name>
<name><surname>Arisio</surname><given-names>R</given-names></name>
<name><surname>Mostert</surname><given-names>M</given-names></name>
<name><surname>Leonessa</surname><given-names>M</given-names></name>
<name><surname>Farina</surname><given-names>D</given-names></name>
<name><surname>Latino</surname><given-names>MA</given-names></name>
<etal/>
</person-group>
<article-title>Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study</article-title>
<source>Pediatrics</source>
<year>2006</year>
<volume>117</volume>
<fpage>e22</fpage>
<lpage>32</lpage>
</element-citation></ref>
<ref id="b30-cep-2019-01431">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Benjamin</surname><given-names>DK</given-names><suffix>Jr</suffix></name>
<name><surname>Hudak</surname><given-names>ML</given-names></name>
<name><surname>Duara</surname><given-names>S</given-names></name>
<name><surname>Randolph</surname><given-names>DA</given-names></name>
<name><surname>Bidegain</surname><given-names>M</given-names></name>
<name><surname>Mundakel</surname><given-names>GT</given-names></name>
<etal/>
</person-group>
<article-title>Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial</article-title>
<source>JAMA</source>
<year>2014</year>
<volume>311</volume>
<fpage>1742</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b31-cep-2019-01431">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kirpal</surname><given-names>H</given-names></name>
<name><surname>Gathwala</surname><given-names>G</given-names></name>
<name><surname>Chaudhary</surname><given-names>U</given-names></name>
<name><surname>Sharma</surname><given-names>D</given-names></name>
</person-group>
<article-title>Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial</article-title>
<source>J Matern Fetal Neonatal Med</source>
<year>2016</year>
<volume>29</volume>
<fpage>624</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b32-cep-2019-01431">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>JP</given-names></name>
<name><surname>Thompson</surname><given-names>SG</given-names></name>
</person-group>
<article-title>Quantifying heterogeneity in a meta-analysis</article-title>
<source>Stat Med</source>
<year>2002</year>
<volume>21</volume>
<fpage>1539</fpage>
<lpage>58</lpage>
</element-citation></ref>
<ref id="b33-cep-2019-01431">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hope</surname><given-names>WW</given-names></name>
<name><surname>Castagnola</surname><given-names>E</given-names></name>
<name><surname>Groll</surname><given-names>AH</given-names></name>
<name><surname>Roilides</surname><given-names>E</given-names></name>
<name><surname>Akova</surname><given-names>M</given-names></name>
<name><surname>Arendrup</surname><given-names>MC</given-names></name>
<etal/>
</person-group>
<article-title>ESCMID&#x0002a; guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by <italic>Candida</italic> spp</article-title>
<source>Clin Microbiol Infect</source>
<year>2012</year>
<volume>18 Suppl 7</volume>
<fpage>38</fpage>
<lpage>52</lpage>
</element-citation></ref>
<ref id="b34-cep-2019-01431">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Santolaya</surname><given-names>ME</given-names></name>
<name><surname>Alvarado Matute</surname><given-names>T</given-names></name>
<name><surname>de Queiroz Telles</surname><given-names>F</given-names></name>
<name><surname>Colombo</surname><given-names>AL</given-names></name>
<name><surname>Zurita</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>Recommendations for the management of candidemia in neonates in Latin America. Latin America Invasive Mycosis Network</article-title>
<source>Rev Iberoam Micol</source>
<year>2013</year>
<volume>30</volume>
<fpage>158</fpage>
<lpage>70</lpage>
</element-citation></ref>
<ref id="b35-cep-2019-01431">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Figueras</surname><given-names>C</given-names></name>
<name><surname>D&#x000ed;az de Heredia</surname><given-names>C</given-names></name>
<name><surname>Garc&#x000ed;a</surname><given-names>JJ</given-names></name>
<name><surname>Navarro</surname><given-names>M</given-names></name>
<name><surname>Ruiz-Contreras</surname><given-names>J</given-names></name>
<name><surname>Rossich</surname><given-names>R</given-names></name>
<etal/>
</person-group>
<article-title>Recomendaciones de la Sociedad Espa&#x000f1;ola de Infectolog&#x000ed;a Pedi&#x000e1;trica sobre diagn&#x000f3;stico y tratamiento de la candidiasis invasiva [The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis]</article-title>
<source>An Pediatr (Barc)</source>
<year>2011</year>
<volume>74</volume>
<fpage>337.e1</fpage>
<lpage>337.e17</lpage>
</element-citation></ref>
<ref id="b36-cep-2019-01431">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pappas</surname><given-names>PG</given-names></name>
<name><surname>Kauffman</surname><given-names>CA</given-names></name>
<name><surname>Andes</surname><given-names>DR</given-names></name>
<name><surname>Clancy</surname><given-names>CJ</given-names></name>
<name><surname>Marr</surname><given-names>KA</given-names></name>
<name><surname>Ostrosky-Zeichner</surname><given-names>L</given-names></name>
<etal/>
</person-group>
<article-title>Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America</article-title>
<source>Clin Infect Dis</source>
<year>2016</year>
<volume>62</volume>
<fpage>e1</fpage>
<lpage>50</lpage>
</element-citation></ref>
<ref id="b37-cep-2019-01431">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Benjamin</surname><given-names>DK</given-names><suffix>Jr</suffix></name>
<name><surname>Stoll</surname><given-names>BJ</given-names></name>
<name><surname>Gantz</surname><given-names>MG</given-names></name>
<name><surname>Walsh</surname><given-names>MC</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>PJ</given-names></name>
<name><surname>Das</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<article-title>Neonatal candidiasis: epidemiology, risk factors, and clinical judgment</article-title>
<source>Pediatrics</source>
<year>2010</year>
<volume>126</volume>
<fpage>e865</fpage>
<lpage>73</lpage>
</element-citation></ref>
<ref id="b38-cep-2019-01431">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cleminson</surname><given-names>J</given-names></name>
<name><surname>Austin</surname><given-names>N</given-names></name>
<name><surname>McGuire</surname><given-names>W</given-names></name>
</person-group>
<article-title>Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants</article-title>
<source>Cochrane Database Syst Rev</source>
<year>2015</year>
<volume>2015</volume>
<fpage>CD003850</fpage>
</element-citation></ref>
<ref id="b39-cep-2019-01431">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rios</surname><given-names>JFDS</given-names></name>
<name><surname>Camargos</surname><given-names>PAM</given-names></name>
<name><surname>Corr&#x000ea;a</surname><given-names>LP</given-names></name>
<name><surname>Romanelli</surname><given-names>RMC</given-names></name>
</person-group>
<article-title>Fluconazole prophylaxis in preterm infants: a systematic review</article-title>
<source>Braz J Infect Dis</source>
<year>2017</year>
<volume>21</volume>
<fpage>333</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b40-cep-2019-01431">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Blyth</surname><given-names>CC</given-names></name>
<name><surname>Barzi</surname><given-names>F</given-names></name>
<name><surname>Hale</surname><given-names>K</given-names></name>
<name><surname>Isaacs</surname><given-names>D</given-names></name>
</person-group>
<article-title>Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin</article-title>
<source>J Paediatr Child Health</source>
<year>2012</year>
<volume>48</volume>
<fpage>846</fpage>
<lpage>51</lpage>
</element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-cep-2019-01431" position="float">
<label>Fig. 1.</label><caption><p>Study selection process.</p></caption>
<graphic xlink:href="cep-2019-01431f1.tif"/></fig>
<fig id="f2-cep-2019-01431" position="float">
<label>Fig. 2.</label><caption><p>Forest plot of risk ratio between prophylaxis with fluconazole and no prophylaxis for mortality in very low birth weight infants. CI, confidence interval.</p></caption>
<graphic xlink:href="cep-2019-01431f2.tif"/></fig>
<fig id="f3-cep-2019-01431" position="float">
<label>Fig. 3.</label><caption><p>Forest plot of risk ratio between prophylaxis with fluconazole and no prophylaxis for invasive candidiasis-associated mortality in very low birth weight infants. CI, confidence interval.</p></caption>
<graphic xlink:href="cep-2019-01431f3.tif"/></fig>
<fig id="f4-cep-2019-01431" position="float">
<label>Fig. 4.</label><caption><p>Forest plot of risk ratio between prophylaxis with fluconazole and no prophylaxis for colonization in very low birth weight infants. CI, confidence interval.</p></caption>
<graphic xlink:href="cep-2019-01431f4.tif"/></fig>
<fig id="f5-cep-2019-01431" position="float">
<label>Fig. 5.</label><caption><p>Forest plot of risk ratio between prophylaxis with fluconazole and no prophylaxis for invasive candidiasis in very low birth weight infants. CI, confidence interval.</p></caption>
<graphic xlink:href="cep-2019-01431f5.tif"/></fig>
<fig id="f6-cep-2019-01431" position="float">
<label>Fig. 6.</label><caption><p>Funnel plot of standard error by log risk ratio.</p></caption>
<graphic xlink:href="cep-2019-01431f6.tif"/></fig>
<fig id="f7-cep-2019-01431" position="float">
<graphic xlink:href="cep-2019-01431f7.tif"/></fig>
<table-wrap id="t1-cep-2019-01431" position="float">
<label>Table 1.</label>
<caption><p>Study characteristics</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle" rowspan="2">Study</th>
<th align="center" valign="middle" colspan="5">Fluconazole group<hr/></th>
<th align="center" valign="middle" colspan="2">Control group<hr/></th>
</tr><tr>
<th align="center" valign="middle">Number</th>
<th align="center" valign="middle">Weight</th>
<th align="center" valign="middle">Dose</th>
<th align="center" valign="middle">Frequency</th>
<th align="center" valign="middle">Duration</th>
<th align="center" valign="middle">Number</th>
<th align="center" valign="middle">Weight</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Kaufman et al. [<xref ref-type="bibr" rid="b8-cep-2019-01431">8</xref>] (2001)</td>
<td valign="top" align="center">50</td>
<td valign="top" align="left">&lt;1,000 g</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 3 or 2 or 1 days</td>
<td valign="top" align="left">Weeks 1, 2/3, 4/5, 6</td>
<td valign="top" align="center">50</td>
<td valign="top" align="left">&lt;1,000 g</td>
</tr>
<tr>
<td valign="top" align="left">Jannatdoust et al. [<xref ref-type="bibr" rid="b22-cep-2019-01431">22</xref>] (2015)</td>
<td valign="top" align="center">43</td>
<td valign="top" align="left">&lt;1,250 g</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 3 or 2 or 1 days</td>
<td valign="top" align="left">Weeks 1, 2/3, 4/5, 6</td>
<td valign="top" align="center">50</td>
<td valign="top" align="left">&lt;1,250 g</td>
</tr>
<tr>
<td valign="top" align="left">Aghai et al. [<xref ref-type="bibr" rid="b23-cep-2019-01431">23</xref>] (2006)</td>
<td valign="top" align="center">140</td>
<td valign="top" align="left">&#x02264;1,000 g</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 3 or 2 or 1 days</td>
<td valign="top" align="left">Weeks 1, 2/3, 4/5, 6</td>
<td valign="top" align="center">136</td>
<td valign="top" align="left">&#x02264;1,000 g</td>
</tr>
<tr>
<td valign="top" align="left">Healy et al. [<xref ref-type="bibr" rid="b12-cep-2019-01431">12</xref>] (2008)</td>
<td valign="top" align="center">448</td>
<td valign="top" align="left">&lt;1,000</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 3 or 2 or 1 days</td>
<td valign="top" align="left">Weeks 1, 2/3, 4/5, 6</td>
<td valign="top" align="center">206</td>
<td valign="top" align="left">&lt;1,000 g</td>
</tr>
<tr>
<td valign="top" align="left">Healy et al. [<xref ref-type="bibr" rid="b24-cep-2019-01431">24</xref>] (2005)</td>
<td valign="top" align="center">240</td>
<td valign="top" align="left">&lt;1,000</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 3 or 2 or 1 days</td>
<td valign="top" align="left">Weeks 1, 2/3, 4/5, 6</td>
<td valign="top" align="center">206</td>
<td valign="top" align="left">&lt;1,000 g</td>
</tr>
<tr>
<td valign="top" align="left">Lee et al. [<xref ref-type="bibr" rid="b15-cep-2019-01431">15</xref>] (2016)</td>
<td valign="top" align="center">264</td>
<td valign="top" align="left">&lt;1,000 g</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Twice weekly</td>
<td valign="top" align="left">4 Weeks</td>
<td valign="top" align="center">159</td>
<td valign="top" align="left">&lt;1,000 g</td>
</tr>
<tr>
<td valign="top" align="left">Weitkamp et al. [<xref ref-type="bibr" rid="b25-cep-2019-01431">25</xref>] (2008)</td>
<td valign="top" align="center">42</td>
<td valign="top" align="left">&lt;750 g</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Twice weekly</td>
<td valign="top" align="left">4 Weeks</td>
<td valign="top" align="center">44</td>
<td valign="top" align="left">&lt;750 g</td>
</tr>
<tr>
<td valign="top" align="left">Rueda et al. [<xref ref-type="bibr" rid="b26-cep-2019-01431">26</xref>] (2010)</td>
<td valign="top" align="center">252</td>
<td valign="top" align="left">&lt;1,250</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 2 days</td>
<td valign="top" align="left">6 Weeks</td>
<td valign="top" align="center">271</td>
<td valign="top" align="left">&lt;1,250</td>
</tr>
<tr>
<td valign="top" align="left">Aydemir et al. [<xref ref-type="bibr" rid="b27-cep-2019-01431">27</xref>] (2010)</td>
<td valign="top" align="center">93</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 3 days</td>
<td valign="top" align="left">30&#x02013;45 Days</td>
<td valign="top" align="center">91</td>
<td valign="top" align="left">&lt;1,500 g</td>
</tr>
<tr>
<td valign="top" align="left">Manzoni et al. [<xref ref-type="bibr" rid="b10-cep-2019-01431">10</xref>] (2007a)</td>
<td valign="top" align="center">104</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">3 mg/kg</td>
<td valign="top" align="left">Every 3 days/every 2 days</td>
<td valign="top" align="left">First 2 weeks/weeks 3&#x02013;6</td>
<td valign="top" align="center">106</td>
<td valign="top" align="left">&lt;1,500 g</td>
</tr>
<tr>
<td valign="top" align="left">Manzoni et al. [<xref ref-type="bibr" rid="b10-cep-2019-01431">10</xref>] (2007b)</td>
<td valign="top" align="center">112</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">6 mg/kg</td>
<td valign="top" align="left">Every 3 days/every 2 days</td>
<td valign="top" align="left">First 2 weeks/weeks 3&#x02013;6</td>
<td valign="top" align="center">106</td>
<td valign="top" align="left">&lt;1,500 g</td>
</tr>
<tr>
<td valign="top" align="left">Bertini et al. [<xref ref-type="bibr" rid="b28-cep-2019-01431">28</xref>] (2005)</td>
<td valign="top" align="center">136</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">6 mg/kg</td>
<td valign="top" align="left">Every 3 days/once daily</td>
<td valign="top" align="left">First week/weeks 2, 3 ,4</td>
<td valign="top" align="center">119</td>
<td valign="top" align="left">&lt; 1500 g</td>
</tr>
<tr>
<td valign="top" align="left">Manzoni et al. [<xref ref-type="bibr" rid="b29-cep-2019-01431">29</xref>] (2006)</td>
<td valign="top" align="center">225</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">6 mg/kg</td>
<td valign="top" align="left">Every 3 days first week then every 2 days</td>
<td valign="top" align="left">Until 30th&#x02013;45th day of life</td>
<td valign="top" align="center">240</td>
<td valign="top" align="left">&lt;1,500 g</td>
</tr>
<tr>
<td valign="top" align="left">Benjamin et al. [<xref ref-type="bibr" rid="b30-cep-2019-01431">30</xref>] (2014)</td>
<td valign="top" align="center">188</td>
<td valign="top" align="left">&lt;750 g</td>
<td valign="top" align="center">6 mg/kg</td>
<td valign="top" align="left">Twice weekly</td>
<td valign="top" align="left">6 Weeks</td>
<td valign="top" align="center">173</td>
<td valign="top" align="left">&lt;750 g</td>
</tr>
<tr>
<td valign="top" align="left">Parikh et al. [<xref ref-type="bibr" rid="b11-cep-2019-01431">11</xref>] (2007)</td>
<td valign="top" align="center">60</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">6 mg/kg</td>
<td valign="top" align="left">Every 3 days/once daily</td>
<td valign="top" align="left">First week/weeks 2, 3 ,4</td>
<td valign="top" align="center">60</td>
<td valign="top" align="left">&lt;1,500 g</td>
</tr>
<tr>
<td valign="top" align="left">Kicklighter et al. [<xref ref-type="bibr" rid="b9-cep-2019-01431">9</xref>] (2001)</td>
<td valign="top" align="center">53</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">6 mg/kg</td>
<td valign="top" align="left">Every 3 days/every days</td>
<td valign="top" align="left">Weeks 1/2, 3, 4</td>
<td valign="top" align="center">50</td>
<td valign="top" align="left">&lt;1,500 g</td>
</tr>
<tr>
<td valign="top" align="left">Kirpal et al. [<xref ref-type="bibr" rid="b31-cep-2019-01431">31</xref>] (2016)</td>
<td valign="top" align="center">38</td>
<td valign="top" align="left">&lt;1,500 g</td>
<td valign="top" align="center">6 mg/kg</td>
<td valign="top" align="left">Every 2 or 1 days</td>
<td valign="top" align="left">Weeks 1/2, 3, 4</td>
<td valign="top" align="center">37</td>
<td valign="top" align="left">&lt;1,500 g</td>
</tr>
</tbody></table>
</table-wrap>

<table-wrap id="t2-cep-2019-01431" position="float">
<label>Table 2.</label>
<caption><p>Study outcomes of prophylactic fluconazole use in newborns</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Study</th>
<th align="center" valign="middle">Study type</th>
<th align="center" valign="middle">Outcome</th>
<th align="center" valign="middle"><italic>P</italic> value</th>
<th align="center" valign="middle">Effect: no prophylaxis/prophylaxis n (%)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="6">Kaufman et al. [<xref ref-type="bibr" rid="b8-cep-2019-01431">8</xref>] (2001)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">30/50 (60)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.008</td>
<td valign="top" align="center">11/50 (22)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="4">Mortality</td>
<td valign="top" align="center">0.22</td>
<td valign="top" align="center">10/50(20)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">10/50 (20)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">4/50 (8)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Jannatdoust et al. [<xref ref-type="bibr" rid="b22-cep-2019-01431">22</xref>] (2015)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left" rowspan="2">Mortality</td>
<td valign="top" align="center">0.045</td>
<td valign="top" align="center">15/50 (30)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">9/43 (20)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="4">Aghai et al. [<xref ref-type="bibr" rid="b23-cep-2019-01431">23</xref>] (2006)</td>
<td valign="top" align="left">Cohort</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.006</td>
<td valign="top" align="center">9 (6.6)</td>
</tr>
<tr>
<td valign="top" align="left">98-05</td>
<td valign="top" align="left" rowspan="3">Mortality</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">54/137 (39.4)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">36/140 (25.7)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Healy et al. [<xref ref-type="bibr" rid="b12-cep-2019-01431">12</xref>] (2008)</td>
<td valign="top" align="left">Cohortx</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">15/206 (7.3)</td>
</tr>
<tr>
<td valign="top" align="left">00-06</td>
<td valign="top" align="left" rowspan="5">IC-associated mortality</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">9/448 (2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">0.13</td>
<td valign="top" align="center">4/206 (2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">40/206 (19)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">65/448 (15)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Healy et al. [<xref ref-type="bibr" rid="b24-cep-2019-01431">24</xref>] (2005)</td>
<td valign="top" align="left">Cohort</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">15/206 (7)</td>
</tr>
<tr>
<td valign="top" align="left">02-04</td>
<td valign="top" align="left" rowspan="5">IC-associated mortality</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">5/240 (2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">0.8</td>
<td valign="top" align="center">4/206 (2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">33/206 (16)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">41/240 (17)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="8">Lee et al. [<xref ref-type="bibr" rid="b15-cep-2019-01431">15</xref>] (2016)</td>
<td valign="top" align="left">Cohort</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">0.001</td>
<td valign="top" align="center">88/149 (59.1)</td>
</tr>
<tr>
<td valign="top" align="left">03-13</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.80</td>
<td valign="top" align="center">76/224 (33.9)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Mortality</td>
<td valign="top" align="center">0.18</td>
<td valign="top" align="center">7/159 (4.4)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="5">IC-associated mortality</td>
<td valign="top" align="center">0.32</td>
<td valign="top" align="center">12/242(5.0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">26/159 (16.4)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">31/264 (11.7)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">3/26 (11.5)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">1/31 (3.2)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Weitkamp et al. [<xref ref-type="bibr" rid="b25-cep-2019-01431">25</xref>] (2008)</td>
<td valign="top" align="left">Cohort</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">&lt;0.05</td>
<td valign="top" align="center">9/44 (20)</td>
</tr>
<tr>
<td valign="top" align="left">04-06</td>
<td valign="top" align="left" rowspan="5">IC-associated mortality</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">&gt;0.05</td>
<td valign="top" align="center">1/9 (11)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">9/44 (20)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">11/42 (26)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="4">Rueda et al. [<xref ref-type="bibr" rid="b26-cep-2019-01431">26</xref>] (2010)</td>
<td valign="top" align="left">Cohort</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">&lt;0.001</td>
<td valign="top" align="center">21/271 (7.7)</td>
</tr>
<tr>
<td valign="top" align="left">08-09</td>
<td valign="top" align="left" rowspan="3">IC-associated mortality</td>
<td valign="top" align="center">&lt;0.05</td>
<td valign="top" align="center">3/252 (1.1)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">16/271 (6)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">2/252 (1)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="8">Aydemir et al. [<xref ref-type="bibr" rid="b27-cep-2019-01431">27</xref>] (2010)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">&lt;0.001</td>
<td valign="top" align="center">39/91 (42.9)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">&lt;0.001</td>
<td valign="top" align="center">10/93 (10.8)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Mortality</td>
<td valign="top" align="center">0.64</td>
<td valign="top" align="center">15/91 (16.5)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="5">IC-associated mortality</td>
<td valign="top" align="center">0.42</td>
<td valign="top" align="center">3/93 (3.2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">8/93 (8.6)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">11/91 (12.1)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">1/93 (1.1)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">3/91 (3.3)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Manzoni et al. [<xref ref-type="bibr" rid="b10-cep-2019-01431">10</xref>] (2007a)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">&lt;0.001</td>
<td valign="top" align="center">31/106 (29.2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">8/104 (7.7)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Overall</td>
<td valign="top" align="center">1.000</td>
<td valign="top" align="center">14/106 (13.2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="3">mortality</td>
<td valign="top" align="center"></td>
<td valign="top" align="center">4/104 (3.8)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">10/106 (9.4)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">9/104 (8.7)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Manzoni et al. [<xref ref-type="bibr" rid="b10-cep-2019-01431">10</xref>] (2007b)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">&lt;0.001</td>
<td valign="top" align="center">31/106 (29.2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.005</td>
<td valign="top" align="center">11/112 (9.8)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Overall</td>
<td valign="top" align="center">0.81</td>
<td valign="top" align="center">14/106 (13.2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="3">mortality</td>
<td valign="top" align="center"></td>
<td valign="top" align="center">3/112 (2.7)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">10/106 (9.4)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">9/112 (8.0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Bertini et al. [<xref ref-type="bibr" rid="b28-cep-2019-01431">28</xref>] (2005)</td>
<td valign="top" align="left">Cohort</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">9/119 (7.6)</td>
</tr>
<tr>
<td valign="top" align="left">98-03</td>
<td valign="top" align="left">Mortality</td>
<td valign="top" align="center">0.32</td>
<td valign="top" align="center">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Manzoni et al. [<xref ref-type="bibr" rid="b29-cep-2019-01431">29</xref>] (2006)</td>
<td valign="top" align="left">Cohort</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">&lt;0.0001</td>
<td valign="top" align="center">15/119 (12.6)</td>
</tr>
<tr>
<td valign="top" align="left">98-03</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">&lt;0.0001</td>
<td valign="top" align="center">11/136 (8.1)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="4">Mortality</td>
<td valign="top" align="center">0.44</td>
<td valign="top" align="center">105/240 (43.8)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">54/225 (24.0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">27/240 (11.2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">24/225 (10.6)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="10">Benjamin Jr et al. [<xref ref-type="bibr" rid="b30-cep-2019-01431">30</xref>] (2014)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">IC &lt;49 days</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">16/188 (9)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">IC before discharge</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">6/173 (3)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Mortality &lt;49 days</td>
<td valign="top" align="center">0.98</td>
<td valign="top" align="center">19/188 (11)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Mortality before discharge</td>
<td valign="top" align="center">0.84</td>
<td valign="top" align="center">8/173 (4)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="6">Neurodevelopment impairment</td>
<td valign="top" align="center">0.6</td>
<td valign="top" align="center">25/188 (14)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">27/173 (14)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">33/188 (19)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">34/173 (18)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">23/84 (27)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">27/87 (31)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Parikh et al. [<xref ref-type="bibr" rid="b11-cep-2019-01431">11</xref>] (2007)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">0.001</td>
<td valign="top" align="center">30/60 (50)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.835</td>
<td valign="top" align="center">11/60 (19)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="4">Mortality</td>
<td valign="top" align="center">1.000</td>
<td valign="top" align="center">15/60 (25)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">16/60 (26.7)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">17/60 (28)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">17/60 (28)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="6">Kicklighter et al. [<xref ref-type="bibr" rid="b9-cep-2019-01431">9</xref>] (2001)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">Colonization</td>
<td valign="top" align="center">0.0005</td>
<td valign="top" align="center">23/5 (46)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">8/53 (15.1)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="4">Mortality</td>
<td valign="top" align="center">0.131</td>
<td valign="top" align="center">2/50 (4)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">3.7 (2/53)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">10/50 (20)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">5/53 (9.4)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="4">Kirpal et al. [<xref ref-type="bibr" rid="b31-cep-2019-01431">31</xref>] (2016)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">16/37 (43.2)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left" rowspan="3">IC-associated mortality</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">8/38 (21.0)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">7/37 (18.9)</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center">1/38 (2.6)</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>IC, invasive candidiasis; RCT, randomized controlled trial.</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t3-cep-2019-01431" position="float">
<label>Table 3.</label>
<caption><p>Results of meta-analysis and fixed model</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle" rowspan="2">Variable</th>
<th align="center" valign="middle" rowspan="2">Group</th>
<th align="center" valign="middle" rowspan="2">No. of studies</th>
<th align="center" valign="middle" colspan="3">Effect size and 95% interval<hr/></th>
<th align="center" valign="middle" colspan="3">Test of null (2-tail)<hr/></th>
<th align="center" valign="middle" colspan="3">Heterogeneity<hr/></th>
</tr><tr>
<th align="center" valign="middle">Point estimate</th>
<th align="center" valign="middle">Lower limit</th>
<th align="center" valign="middle">Upper limit</th>
<th align="center" valign="middle"><italic>Z</italic> value</th>
<th align="center" valign="middle"><italic>P</italic> value</th>
<th align="center" valign="middle"><italic>Q</italic> value</th>
<th align="center" valign="middle"><italic>df</italic> (Q)</th>
<th align="center" valign="middle"><italic>P</italic> value</th>
<th align="center" valign="middle"><italic>I</italic><sup>2</sup></th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="4">Mortality</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.59</td>
<td valign="top" align="center">0.32</td>
<td valign="top" align="center">1.07</td>
<td valign="top" align="center">-1.72</td>
<td valign="top" align="center">0.085</td>
<td valign="top" align="center">0.70</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.404</td>
<td valign="top" align="center">0.000</td>
</tr>
<tr>
<td valign="top" align="center">2</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.78</td>
<td valign="top" align="center">0.63</td>
<td valign="top" align="center">0.97</td>
<td valign="top" align="center">-2.27</td>
<td valign="top" align="center">0.023</td>
<td valign="top" align="center">3.20</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.202</td>
<td valign="top" align="center">37.486</td>
</tr>
<tr>
<td valign="top" align="center">3</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.84</td>
<td valign="top" align="center">0.56</td>
<td valign="top" align="center">1.27</td>
<td valign="top" align="center">-0.81</td>
<td valign="top" align="center">0.419</td>
<td valign="top" align="center">1.55</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.213</td>
<td valign="top" align="center">35.385</td>
</tr>
<tr>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.83</td>
<td valign="top" align="center">0.51</td>
<td valign="top" align="center">1.37</td>
<td valign="top" align="center">-0.73</td>
<td valign="top" align="center">0.468</td>
<td valign="top" align="center">1.63</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.201</td>
<td valign="top" align="center">38.819</td>
</tr>
<tr>
<td valign="top" align="left">IC</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">1.05</td>
<td valign="top" align="center">0.59</td>
<td valign="top" align="center">1.88</td>
<td valign="top" align="center">0.18</td>
<td valign="top" align="center">0.856</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.905</td>
<td valign="top" align="center">0.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Colonization</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.35</td>
<td valign="top" align="center">0.22</td>
<td valign="top" align="center">0.55</td>
<td valign="top" align="center">-4.54</td>
<td valign="top" align="center">0.000</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.813</td>
<td valign="top" align="center">0.000</td>
</tr>
<tr>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.068</td>
<td valign="top" align="center">0.009</td>
<td valign="top" align="center">0.543</td>
<td valign="top" align="center">-2.54</td>
<td valign="top" align="center">0.011</td>
<td valign="top" align="center">0.09</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.768</td>
<td valign="top" align="center">0.000</td>
</tr>
<tr>
<td valign="top" align="left">IC-associated mortality</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.163</td>
<td valign="top" align="center">0.024</td>
<td valign="top" align="center">1.089</td>
<td valign="top" align="center">-1.87</td>
<td valign="top" align="center">0.061</td>
<td valign="top" align="center">0.43</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.513</td>
<td valign="top" align="center">0.000</td>
</tr>
</tbody></table>
</table-wrap>
</sec>
</back></article>